Occluded vessels in the upper extremity are. Copyright HMP Communications

Size: px
Start display at page:

Download "Occluded vessels in the upper extremity are. Copyright HMP Communications"

Transcription

1 Atherectomy in the Occluded Forearm: A Case Presentation of Interosseous Ulnar Artery Treatment Dwight Dishmon, MD From the University of Tennessee Health Science Center, Memphis, Tennessee. ABSTRACT: Purpose: Endovascular interventions in the arm can be essential in saving an affected limb. A difficult case of ulnar occlusion is described. Case Report: A 69-year-old male was referred to the clinic with gangrenous changes to the right first and second fingers. The patient had a variety of comorbidities and a recent history of mitral valve replacement. Angiography identified a total occlusion of the ulnar artery and limited flow to the hand. Atherectomy was performed using an orbital atherectomy system and a balloon was passed and inflated in the interosseous artery. Excellent flow was obtained into the hand; however, there was no flow in the gangrenous portion of the digits. The patient returned 10 days later for partial amputation of the fingers but has had no revascularization and no new wounds on the treated forearm. Conclusion: This case illustrates the benefit of endovascular intervention in patients with forearm and hand occlusions. VASCULAR DISEASE MANAGEMENT 2016;13(4):E95-E100 Key words: orbital atherectomy, ulnar artery, limb salvage, endovascular therapy Occluded vessels in the upper extremity are most often treated with amputation of the affected digits or hand and, less frequently, surgical bypass is performed to restore blood flow. Amputation carries many risks and results in permanent disability for the patient. Surgical interventions of occluded vessels have focused on bypass grafting, often from the saphenous vein; 1 however, these techniques are invasive, carry risks of infection, and may result in a longer recovery time. Superficial grafts distal to the wrist should also be carefully considered because the hand is particularly prone to trauma, and grafts may be more likely to become occluded due to flexion and extension of the hand. 2 Neither amputation nor surgical bypass is ideal for every patient and new endovascular treatment options are being used in the forearm. Endovascular treatment of the forearm is difficult due to small vessel size; however, this treatment option is similarly as challenging as endovascular intervention below the knee. The right and left ulnar arteries have average diameters of 2.3 mm and 2.4 mm, respectively, and the right and left radial arteries have average diameters of 2.3 mm and 2.2 mm, respectively. 3 Comparatively, these vessel sizes are similar to those found below the knee, but larger than those found below the ankle. Physicians are beginning to treat chronic hand ischemia patients with percutaneous transluminal Vascular Disease Management April

2 Figure 1. The patient presented with a large occlusion in the ulnar artery (A) and flow to the hand was poor (B). balloon angioplasty. 4,5 Balloon angioplasty is prone to pain and gangrenous changes in the first and second higher rates of restenosis; 6 therefore, atherectomy is a fingers of the right hand. He had a history of obesity, combined therapy often employed in the periphery. In many cases, atherectomy is not typically considered due to the small anatomy of vessels in the forearm; however, the orbital atherectomy system (OAS) (Cardiovascular Systems, Inc.) can enter vessels with reference vessel diameters as small as 1.5 mm. As below-the-knee interventions are gaining popularity, 7,8 physicians are hopeful that the need for interventions in the upper extremity will become more apparent. This case details the use of atherectomy in the interosseous ulnar artery. CASE REPORT A 69-year-old male was referred to the clinic with diabetes, and hypertension; he recently underwent a mitral valve replacement and had an identified thrombus in his jugular vein. The primary care physician identified that the patient s right hand was swollen and capillary refill was absent in the first and second fingers. The primary care physician was pessimistic about the ability to save the patient s first and second fingers, but hopeful that more proximal tissue could be saved depending on the location of the occlusion. Angiography identified a total occlusion of the radial artery and an occlusion in the interosseous ulnar artery (Figure 1A) and flow to the hand was poor (Figure 1B). Endovascular intervention was performed in an Vascular Disease Management April

3 Figure 2. Orbital atherectomy was performed in the ulnar artery (A) and a balloon was passed distally into the interosseous ulnar artery (B). effort to salvage the patient s right hand and affected digits. Using the modified Seldinger technique, a 6 Fr sheath was placed in the brachial artery. A total occlusion in the right radial artery was crossed and treated by with 2.5 mm x 30 mm Apex balloon (Boston Scientific). Treatment resulted in less than 20% residual stenosis. Brisk anterograde flow was restored to the fingers and attention was turned to an occlusion in the interosseous ulnar artery (Figure 1A). A Prowater wire (Asahi) was used to transverse the stenosis. The Prowater wire was exchanged for a ViperWire (Cardiovascular Systems, Inc.) and a 1.25 mm (145 cm shaft length) Diamondback 360 Peripheral OAS (Cardiovascular Systems, Inc.) was advanced over the wire into the interosseous ulnar artery (Figure 2A). Sequential atherectomy passes were performed and the catheter was removed and exchanged for a tapering 2.5 mm x 210 mm NanoCross balloon (Covidien) (Figure 2B). Following balloon angioplasty, there was an improved angiographic result with restoration of flow into the hand and third and fourth fingers, as well as less than 30% residual stenosis of the interosseous ulnar artery (Figures 3A and 3B). However, flow to the diseased fingers was still poor, suggesting that necrosis was fairly advanced or additional occlusions were present within the digits. The procedure was well tolerated by the patient, with no acute procedural complications and positive angiography results were achieved at the conclusion of the interventions. The patient returned for a follow-up appointment 10 days after the index procedure; both the first and second fingers remained gangrenous and necrotic. The patient was scheduled for a partial amputation of the two fingertips and the procedure was carried out. The patient had good healing of the amputated fingertips (Figure 4) and maintains full use of his hand. The Vascular Disease Management April

4 Figure 3. After treatment, the ulnar artery was highly patent (A) and there was good flow to the hand (B). Flow into the gangrenous fingers was still poor, indicating that the necrosis was fairly advanced. Figure 4. Ten days after the index procedure, the patient returned to have the gangrenous tissue removed from his fingertips. After more than 1.5 years post index procedure, the patient has not needed any repeat interventions on the affected forearm. Vascular Disease Management April

5 patient has been followed for over 1.5 years and has not returned to the clinic for additional endovascular or surgical interventions to the right forearm. DISCUSSION Occluded arteries in the upper extremity can be especially debilitating because hand and digit amputations may severely impact a patient s lifestyle and ability to work. Hand and digit amputations can cause extreme stress for patients, which sometimes develops into posttraumatic stress disorder, and these symptoms could be brought on simply by visualizing the traumatized body part. 9 Endovascular treatments of hand and forearm occlusions are possible and they can reduce or even prevent the need for amputations. There are many lessen the high restenosis rate with balloon angioplasty reasons to consider endovascular intervention for the occluded upper extremity. Because of the amount of summary suffered from systemic atherosclerosis. With the increasing prevalence of atherosclerosis, vascular calcification also presents a challenge in identifying the best course of treatment. 12 Balloon angioplasty has a high rate of restenosis: in the study of angioplasty below the elbow, 18% had restenosis during a 13±9 month follow-up period. 10 However, drugeluting technologies are lagging in their introduction to the upper extremity. Drug-eluting stents are too large to fit below the elbow and drug-coated balloons have shown poor results in more distal vessels. 13 Additionally, recent results suggest that drug delivery is hampered in the presence of calcium. 14 For these reasons, vessel preparation may be necessary in order to treatment. In this case, the lesion was treated with an OAS prior to balloon angioplasty, and this provided flexion and extension of the hand and forearm, bypass a positive result. To our knowledge, this is the first grafts are not ideal and may be prone to additional published case of atherectomy in the occluded forearm. wear. 2 Patients with wounds and poor blood flow are Atherectomy may provide an alternative to balloon sometimes unsuitable candidates for surgery because angioplasty alone and could be a suitable combined the additional wound may not heal correctly or could therapy as new technologies emerge. become infected. 1 Endovascular treatment of the upper extremity is still gaining popularity; however, recent CONCLUSION below-the-elbow studies have shown that angioplasty This patient was successfully treated using an OAS, is safe. 10 A recent literature review and case study also and flow to the hand was restored after intervention. highlighted the value of endovascular approaches in This case illustrates the utility of peripheral intervention to reduce the severity of amputation in occluded the upper extremity the authors note that patients with diabetes, end-stage-renal-disease, and systemic vessels of the hand. n atherosclerosis are more likely to suffer from occlusions in the forearm and hand. 11 These conditions may Editor s note: The author has completed and returned hamper the development of rich collateral that usually supplies the hand and forearm when occlusions Interest. Dr. Dishmon reports receiving travel reimbursement the ICMJE Form for Disclosure of Potential Conflicts of are present in main arteries. 11 The patient in this case from Cardiovascular Systems, Inc. Vascular Disease Management April

6 Manuscript received September 29, 2015; manuscript accepted January 21, Address for correspondence: Dwight Dishmon, MD, UT Methodist Physicians, The University of Tennessee Health Science Center, 920 Court Avenue, Memphis, TN 38163, USA. REFERENCES 1. Weber R, Benacquista T, Suggs W, Herman CK, Strauch B. Palmar arch revascularization for arterial occlusion of the distal upper extremity. J Reconstr Microsurg. 2005;21(5): Dunn AA, Belek KA, Devcic Z, et al. Surgical treatment options for subacute ischemia of the hand: case report and literature review. Eplasty. 2010;10:e Ashraf T, Panhwar Z, Habib S, Memon MA, Shamsi F, Arif J. Size of radial and ulnar artery in local population. J Pak Med Assoc. 2010;60(10): Gandini R, Angelopoulos G, Da Ros V, Simonetti G. Percutaneous transluminal angioplasty for treatment of critical hand ischemia with a novel endovascular approach: the radial to ulnar artery loop technique. J Vasc Surg. 2010;51(3): Kawarada O, Yokoi Y, Higashimori A. Angioplasty of ulnar or radial arteries to treat critical hand ischemia: use of 3- and 4-French systems. Catheter Cardiovasc Interv. 2010;76(3): Schillinger M, Minar E. Restenosis after percutaneous angioplasty: the role of vascular inflammation. Vasc Health Risk Manag. 2005;1(1): Jens S, Conijn AP, Koelemay MJW, Bipat S, Reekers JA. Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and metaanalysis (part 2: below the knee). Eur J Vasc Endovasc Surg. 2014;47(5): Park SW, Kim JS, Yun IJ, et al. Clinical outcomes of endovascular treatments for critical limb ischemia with chronic total occlusive lesions limited to below-the-knee arteries. Acta Radiol. 2013;54: Gustafsson M, Amilon A, Ahlström G. Trauma-related distress and mood disorders in the early stage of an acute traumatic hand injury. J Hand Surg Br. 2003;28(4): Ferraresi R, Palloshi A, Aprigliano G, et al. Angioplasty of below-the-elbow arteries in critical hand ischaemia. Eur J Vasc Endovasc Surg. 2012;43(1): Arabi M, Ahmed I, Qattan N. Transluminal recanalization of chronic total occlusion of radial artery using rendezvous technique: a case report and literature review. J Clin Imaging Sci. 2014;4: Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212-E Zeller T, Baumgartner I, Scheinert D, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol. 2014;64(15): Fanelli F, Cannavale A, Gazzetti M, et al. Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease. Cardiovasc Intervent Radiol. 2014;37(4): Vascular Disease Management April

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division

John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,

More information

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee Marianne Brodmann, MD Medical University Graz Graz, Austria Critical Limb Ischemia Infrapopliteal arterial disease is a leading source

More information

Access strategy for chronic total occlusions (CTOs) is crucial

Access strategy for chronic total occlusions (CTOs) is crucial Learn How Access Strategy Impacts Complex CTO Crossing Arthur C. Lee, MD The Cardiac & Vascular Institute, Gainesville, Florida VASCULAR DISEASE MANAGEMENT 2018;15(3):E19-E23. Key words: chronic total

More information

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller One Year after In.Pact Deep: Lessons learned from a failed trial Prof. Dr. Thomas Zeller Disclosure Speaker name: Thomas Zeller... I have the following potential conflicts of interest to report: x Consulting:

More information

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential

More information

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide 2-Year Results Of The Tack Optimized Balloon Angioplasty (TOBA) Trial For Fem- Pop Lesions Demonstrates Safety and Efficacy Of The Tack Endovascular System In Repairing Focal Post-PTA Dissections Christian

More information

Endovascular Should Be Considered First Line Therapy

Endovascular Should Be Considered First Line Therapy Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach

More information

Turbo-Power. Laser atherectomy catheter. The standard. for ISR

Turbo-Power. Laser atherectomy catheter. The standard. for ISR Turbo-Power Laser atherectomy catheter The standard for ISR Vaporize the ISR challenge In-stent restenosis (ISR) Chance of recurring 7 115,000 + /year (U.S.) 1-6 Repeated narrowing of the arteries after

More information

The Utility of Atherectomy and the Jetstream Atherectomy System

The Utility of Atherectomy and the Jetstream Atherectomy System The Utility of Atherectomy and the Jetstream Atherectomy System William A. Gray, MD Columbia University Medical Center 2014 Boston Scientific Corporation or its affiliates. All rights reserved. IMPORTANT

More information

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge

9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge Disclosures State-of-the-Art Endovascular Lower Extremity Revascularization Promotional Speaker Jansen Pharmaceutical Promotional Speaker Amgen Pharmaceutical C. Michael Brown, MD, FACC al Cardiology Associate

More information

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview

Disclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott

More information

Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy

Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department Careggi  University Hospital Florence - Italy Don t Use Risky and Embolizing Drug Coated Balloons Below The Knee! Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy

More information

Angiosome concept myth or truth? Does it make a real difference in real world cases?

Angiosome concept myth or truth? Does it make a real difference in real world cases? Angiosome concept myth or truth? Does it make a real difference in real world cases? Osamu Iida, MD, FACC Kansai Rosai Hospital Amagasaki, Hyogo, Japan Disclosure Speaker name:... I have the following

More information

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Faculty Disclosure Thomas Zeller, MD For the 12 months preceding this presentation, I disclose the following types of

More information

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have

More information

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan

Olive registry: 3-years outcome of BTK intervention in Japan. Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan Olive registry: 3-years outcome of BTK intervention in Japan Osamu Iida, MD Kansai Rosai Hospital Amagasaki, Hyogo, Japan What is the optimal treatment for the patient with critical limb ischemia (CLI)?

More information

Imaging Strategy For Claudication

Imaging Strategy For Claudication Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon

More information

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC 2017 January 25 th 2017 Disclosure

More information

Can t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions

Can t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions Can t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions Vinayak Subramanian, BS 1 ; George L. Adams, MD, MHS 2 From 1 Department of Biomedical Engineering, North Carolina

More information

Update on the OPTIMIZE BTK Trial. Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria

Update on the OPTIMIZE BTK Trial. Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria Update on the OPTIMIZE BTK Trial Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria Disclosure Speaker name: Marianne Brodmann, MD... I have the following potential conflicts

More information

Annals of Vascular Diseases Advance Published Date: June 2, Horie K, et al.

Annals of Vascular Diseases Advance Published Date: June 2, Horie K, et al. 2016 Annals of Vascular Diseases doi:10.3400/avd.cr.16-00007 Case Report Recanalization of a Heavily Calcified Chronic Total Occlusion in a Femoropopliteal Artery Using a Wingman Crossing Catheter Kazunori

More information

Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography

Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography Jon C. George, MD; Vincent Varghese, DO From the Deborah Heart and Lung Center, Browns Mills, New Jersey. ABSTRACT:

More information

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis

Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Osamu Iida, MD From the Kansai Rosai Hospital Cardiovascular Center, Amagasaki City, Japan. ABSTRACT: Approximately

More information

There are multiple endovascular options for treatment

There are multiple endovascular options for treatment Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA

More information

Making the difference with Live Image Guidance

Making the difference with Live Image Guidance Live Image Guidance 2D Perfusion Making the difference with Live Image Guidance In Peripheral Arterial Disease Real-time results, instant assessment Severe foot complications the result of hampered blood

More information

Interventional Treatment First for CLI

Interventional Treatment First for CLI Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075 Disclosures Consultant

More information

Retrograde Endovascular Revascularization of Anterior Tibial Artery via the Dorsal and Plantar Arches

Retrograde Endovascular Revascularization of Anterior Tibial Artery via the Dorsal and Plantar Arches Case Reportc imedpub Journals www.imedpub.com Journal of Vascular and Endovascular Surgery DOI: 10.21767/2573-4482.100020 Retrograde Endovascular Revascularization of Anterior Tibial Artery via the Dorsal

More information

Specificities for infrapopliteal stents

Specificities for infrapopliteal stents Specificities for infrapopliteal stents Nicolas Diehm, M.D. Swiss Cardiovascular Center Clinical and Interventional Angiology University Hospital Bern, Switzerland Disclosures Speaker`s Bureau: MEDRAD,

More information

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D.

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D. Atherectomy: Jetstream and Directional George S. Chrysant, M.D. Disclosures Abbott Vascular: MAB, consultant, proctor Abiomed: consultant Boston Scientific: MAB, consultant, proctor Medicines Company:

More information

Steal Syndrome: The Role of the Vascular Lab

Steal Syndrome: The Role of the Vascular Lab Steal Syndrome: The Role of the Vascular Lab Eighth Overlook Noninvasive Vascular Lab Symposium Larry A. Scher, M.D. Professor of Surgery Division of Vascular Surgery Montefiore Medical Center Albert Einstein

More information

TOBA II 12-Month Results Tack Optimized Balloon Angioplasty

TOBA II 12-Month Results Tack Optimized Balloon Angioplasty TOBA II 12-Month Results Tack Optimized Balloon Angioplasty William Gray, MD System Chief, Cardiovascular Division Main Line Health, Philadelphia, PA Dissection: The Primary Mechanism of Angioplasty Lesions

More information

Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease?

Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease? Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease? The REALITY trial G. Torsello Münster Disclosure Speaker name: G. Torsello... I have

More information

Use of Laser In BTK Disease (CLI)

Use of Laser In BTK Disease (CLI) Use of Laser In BTK Disease (CLI) Click to edit academic affiliation, practice or hospital logo(s) of preference. Product and/or sponsor logos not permitted, per CME guidelines. Richard Kovach, MD, FACC,

More information

Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty

Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Poster No.: C-2067 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Interventional

More information

Copyright HMP Communications

Copyright HMP Communications Ocelot With Wildcat in a Complicated Superficial Femoral Artery Chronic Total Occlusion Soundos K. Moualla, MD, FACC, FSCAI; Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI From Phoenix Heart Center, Phoenix,

More information

CY2015 Hospital Outpatient: Endovascular Procedure APCs and Complexity Adjustments

CY2015 Hospital Outpatient: Endovascular Procedure APCs and Complexity Adjustments CY2015 Hospital Outpatient: Endovascular Procedure APCs Complexity Adjustments Comprehensive Ambulatory Payment Classifications (c-apcs) CMS finalized the implementation of 25 Comprehensive APC to further

More information

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are

Disclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical

More information

When is below-the-ankle angioplasty indicated and how to introduce it into your practice. Roberto Ferraresi. Peripheral Interventional Unit

When is below-the-ankle angioplasty indicated and how to introduce it into your practice. Roberto Ferraresi. Peripheral Interventional Unit When is below-the-ankle angioplasty indicated and how to introduce it into your practice Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy www.robertoferraresi.it Disclosure Roberto Ferraresi,

More information

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?

Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery

More information

Initial Clinical Experience with a Novel Dedicated Cobalt Chromium Stent for the Treatment of Below-the-knee Arterial Disease

Initial Clinical Experience with a Novel Dedicated Cobalt Chromium Stent for the Treatment of Below-the-knee Arterial Disease Initial Clinical Experience with a Novel Dedicated Cobalt Chromium Stent for the Treatment of Below-the-knee Arterial Disease a report by Angelo Cioppa, Luigi Salemme, Vittorio Ambrosini, Giovanni Sorropago,

More information

BC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8

BC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8 BC Vascular Day Contents Abdominal Aortic Aneurysm 2 3 November 3, 2018 Peripheral Arterial Disease 4 6 Deep Venous Thrombosis 7 8 Abdominal Aortic Aneurysm Conservative Management Risk factor modification

More information

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System Volume 1, Issue 1 Case Report Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System Robert F. Riley * and Bill Lombardi University of Washington Medical Center, Division

More information

Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era

Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era Eur Radiol (2014) 24:793 798 DOI 10.1007/s00330-014-3094-0 VASCULAR-INTERVENTIONAL Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era Fabrizio Fanelli & Alessandro

More information

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry Marianne Brodmann, MD Head of the Clinical Division of Angiology Department of Internal Medicine Medical University

More information

THE NEW ARMENIAN MEDICAL JOURNAL

THE NEW ARMENIAN MEDICAL JOURNAL THE NEW ARMENIAN MEDICAL JOURNAL Vol.10 (2016), Nо 1, p. 57-62 Clinical Research SHORT-TERM OUTCOMES OF ENDOVASCULAR INTERVENTION OF INFRAINGUINAL ARTERIES IN PATIENTS WITH CRITICAL LIMB ISCHEMIA Sultanyan

More information

Endovascular treatment (EVT) has markedly advanced,

Endovascular treatment (EVT) has markedly advanced, Ann Vasc Dis Vol. 6, No. 3; 2013; pp 573 577 Online August 12, 2013 2013 Annals of Vascular Diseases doi:10.3400/avd.oa.13-00055 Original Article A Review of Surgically Treated Patients with Obstruction

More information

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁 Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁 Contents DES in SFA DES in BTK DEB in SFA DEB in BTK Current status of covered stent

More information

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts

More information

CLI Treatment Using Long and Scoring Balloons

CLI Treatment Using Long and Scoring Balloons CLI Treatment Using Long and Scoring Balloons Robert Beasley, MD Director of Vascular and Interven3onal Radiology Mount Sinai Medical Center Miami Beach, FL Disclosures Consultant/Advisory Board: Abbott

More information

The essentials for BTK procedures: wires, balloons, what else

The essentials for BTK procedures: wires, balloons, what else A comprehensive approach to diabetic patient Tx The essentials for BTK procedures: wires, balloons, what else Dai-Do Do Clinical and Interventional Angiology Cardiovascular Department Disclosure Speaker

More information

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines

Recommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular

More information

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures

Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Management of In-stent Restenosis after Lower Extremity Endovascular Procedures Piotr Sobieszczyk, MD Associate Director, Cardiac Catheterization Laboratory Cardiovascular Division and Vascular Medicine

More information

New Modalities and Advanced Techniques: The Role of Crossing Devices and Atherectomy

New Modalities and Advanced Techniques: The Role of Crossing Devices and Atherectomy New Modalities and Advanced Techniques: The Role of Crossing Devices and Atherectomy Satish Gadi, MD FACC FSCAI Interventional Cardiologist, Cardiovascular Institute of the South (CIS) Baton Rouge Clinical

More information

Current Status of Endovascular Therapies for Critical Limb Ischemia

Current Status of Endovascular Therapies for Critical Limb Ischemia Current Status of Endovascular Therapies for Critical Limb Ischemia Bulent Arslan, MD Associate Professor of Radiology Director, Vascular & Interventional Radiology Rush University Medical Center bulent_arslan@rush.edu

More information

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label use of

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label use of IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural steps for the on-label use of referenced technologies as well as current standards of care

More information

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can

Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can Rafael Malgor, MD Assistant Professor of Surgery The University of Oklahoma, Tulsa Endovascular Is The Way To Go: Revascularize As Many Vessels As You Can Background Lower extremity anatomy (below the

More information

Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis

Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related. Iliocaval Thrombosis Percutaneously Inserted AngioVac Suction Thrombectomy for the Treatment of Filter-Related Iliocaval Thrombosis Faiz D. Francis, DO; Gianvito Salerno, MD; Sabbah D. Butty, MD Abstract In the setting of

More information

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

PAD Characterization Within A Healthcare System RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016 PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler, MD September 14, 2016 Interventional Cardiology and Cath Labs Disclosures Research Grants: Agency for Healthcare Research

More information

Copyright HMP Communications

Copyright HMP Communications Treatment of Angioseal-Related Femoral Artery Occlusion Using TurboHawk Directional Atherectomy Anvar Babaev, MD, PhD; David W. Lee, MD; Anna Kurayev, MD; Heather Yang, PA From the Division of Cardiology,

More information

DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes

DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes DCB use in fem-pop lesions of patients with CLI (RCC 4-5): subgroup analysis of IN.PACT Global 12-month outcomes Carlos Mena, MD FACC FSCAI Associate Professor of Medicine - Cardiology Director Cardiac

More information

Infrapopliteal percutaneous transluminal angioplasty (PTA) is an established treatment

Infrapopliteal percutaneous transluminal angioplasty (PTA) is an established treatment Diagn Interv Radiol 217; 23:36 364 Turkish Society of Radiology 217 INTERVENTIONAL RADIOLOGY ORIGINAL ARTICLE Outcomes of infrapopliteal angioplasty for limb salvage based on the updated TASC II classification

More information

Current Vascular and Endovascular Management in Diabetic Vasculopathy

Current Vascular and Endovascular Management in Diabetic Vasculopathy Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery

More information

Endovascular Options in Critical Limb Ischemia: Below The Knee Therapies

Endovascular Options in Critical Limb Ischemia: Below The Knee Therapies Endovascular Options in Critical Limb Ischemia: Below The Knee Therapies Bret N. Wiechmann, MD FSIR FAHA FSVM Vascular & Interventional Physicians Gainesville, Florida Disclosures Consultant: Medcomp Bard

More information

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome

Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb

More information

Amputation-free survival after crural percutaneous transluminal angioplasty for critical limb ischemia

Amputation-free survival after crural percutaneous transluminal angioplasty for critical limb ischemia 403SJS0010.1177/1457496915571403Amputation-free survival after crural percutaneous transluminal angioplasty for critical limb ischemiam. Strøm, et al. Original Article Amputation-free survival after crural

More information

Introduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9

Introduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9 Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...

More information

Vessel Preparation: What does it mean and what are the current tools? Lawrence Garcia, MD St. Elizabeth s Medical Center Boston, MA, USA

Vessel Preparation: What does it mean and what are the current tools? Lawrence Garcia, MD St. Elizabeth s Medical Center Boston, MA, USA Vessel Preparation: What does it mean and what are the current tools? Lawrence Garcia, MD St. Elizabeth s Medical Center Boston, MA, USA Disclosure Statement of Financial Interest Within the past 12 months,

More information

Koen Keirse, MD RZ Tienen, Belgium

Koen Keirse, MD RZ Tienen, Belgium Clinical Benefits of the Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection from the ENTRAP Study Koen Keirse, MD RZ Tienen, Belgium Disclosure Speaker name: Koen Keirse...

More information

Excimer Laser for Coronary Intervention: Case Study RADIAL APPROACH: CORONARY LASER ATHERECTOMY FOR CTO OF THE LAD FOLLOWED BY PTCA NO STENTING

Excimer Laser for Coronary Intervention: Case Study RADIAL APPROACH: CORONARY LASER ATHERECTOMY FOR CTO OF THE LAD FOLLOWED BY PTCA NO STENTING Excimer Laser for Coronary Intervention: Case Study RADIAL APPROACH: CORONARY LASER ATHERECTOMY FOR CTO OF THE LAD FOLLOWED BY PTCA NO STENTING 1 2013 Spectranetics. All Rights Reserved. Approved for External

More information

Device Evolution. Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance. Where Do We Stand? 4/18/2015

Device Evolution. Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance. Where Do We Stand? 4/18/2015 Disclosure Statement of Financial Interest Atherectomy: Where Do We Stand After 12 Years Since FDA Clearance Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement

More information

Efficacy of DEB in Calcification and Subintimal Angioplasty

Efficacy of DEB in Calcification and Subintimal Angioplasty Efficacy of DEB in Calcification and Subintimal Angioplasty Seung-Woon Rha, MD, PhD, FACC, FAHA, FSCAI, FESC, FAPSIC Div of Cardiovascular Intervention and Research Cardiovascular Center, Korea University

More information

Clinical Data Update for Drug Coated Balloons (DCB) Seung-Whan Lee, MD, PhD

Clinical Data Update for Drug Coated Balloons (DCB) Seung-Whan Lee, MD, PhD Clinical Data Update for Drug Coated Balloons (DCB) Seung-Whan Lee, MD, PhD Asan Medical Center, Heart Institute, University of Ulsan College of Medicine, Werk et al. Circulation Cardiovasc Intervent 2012

More information

Endovascular revascularisation of popliteal artery occlusions: two complex cases

Endovascular revascularisation of popliteal artery occlusions: two complex cases Case Report Singapore Med J 2011, 52(3) e40 Endovascular revascularisation of popliteal occlusions: two complex cases Toh L M H W, Taneja M, Sebastian M G ABSTRACT Peripheral vascular disease -related

More information

Drug eluting stents and balloons in peripheral arterial disease A.T.O. ABDOOL-CARRIM UNIVERSITY OF WITWATERSRAND

Drug eluting stents and balloons in peripheral arterial disease A.T.O. ABDOOL-CARRIM UNIVERSITY OF WITWATERSRAND Drug eluting stents and balloons in peripheral arterial disease A.T.O. ABDOOL-CARRIM UNIVERSITY OF WITWATERSRAND Drug eluting stents and balloons Endovascular treatment now becoming more popular for treatment

More information

Angiosome revascularization strategies in real world practice: how much difference does it make?

Angiosome revascularization strategies in real world practice: how much difference does it make? Angiosome revascularization strategies in real world practice: how much difference does it make? Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have

More information

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN

Case Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center

More information

Tom Eisele, Benedikt M. Muenz, and Grigorios Korosoglou. Department of Cardiology & Vascular Medicine, GRN Hospital Weinheim, Weinheim, Germany

Tom Eisele, Benedikt M. Muenz, and Grigorios Korosoglou. Department of Cardiology & Vascular Medicine, GRN Hospital Weinheim, Weinheim, Germany Case Reports in Vascular Medicine Volume 2016, Article ID 7376457, 4 pages http://dx.doi.org/10.1155/2016/7376457 Case Report Successful Endovascular Repair of an Iatrogenic Perforation of the Superficial

More information

BTK Intervention with Drug- Coated Balloons: Past Lessons and Future Exploration

BTK Intervention with Drug- Coated Balloons: Past Lessons and Future Exploration BTK Intervention with Drug- Coated Balloons: Past Lessons and Future Exploration M Sapoval, C Del Giudice, C Dean Interventional Radiology Dep Hôpital Européen Georges Pompidou APHP, Paris, France IMPORTANT

More information

January 23, Vascular and oncological interventional radiology Paris Descartes University

January 23, Vascular and oncological interventional radiology Paris Descartes University January 23, 2019 First time data release: Paclitaxel-coated balloon in below-the-knee lesions: 6-months results from the Ranger BTK single center study Dr. Costantino Del Giudice Prof Marc Sapoval Vascular

More information

Paclitaxel-coated versus Plain Balloon Angioplasty in the Treatment of Infrainguinal Vein Bypass Stenosis

Paclitaxel-coated versus Plain Balloon Angioplasty in the Treatment of Infrainguinal Vein Bypass Stenosis Paclitaxel-coated versus Plain Balloon Angioplasty in the Treatment of Infrainguinal Vein Bypass Stenosis T. Hölzenbein, A. Ugurluoglu, M. Aspalter, W. Hitzl, K. Linni Dep Vascular & Endovascular Surgery

More information

The incidence of peripheral artery disease (PAD)

The incidence of peripheral artery disease (PAD) Pharmacologic Options for Treating Restenosis The role of cilostazol in the treatment of patients with infrainguinal lesions. By Osamu Iida, MD, and Yoshimitsu Soga, MD The incidence of peripheral artery

More information

Hiroshi Ando, MD Kasukabe Chuo General Hospital Saitama, Japan

Hiroshi Ando, MD Kasukabe Chuo General Hospital Saitama, Japan Hiroshi Ando, MD Kasukabe Chuo General Hospital Saitama, Japan Disclosure Hiroshi Ando, MD Kasukabe Chuo General Hospital I have the following potential conflicts of interest to report: Consulting Employment

More information

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery

Step by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following

More information

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker

More information

Lessons learnt from DES in the SFA is there any ideal concept so far?

Lessons learnt from DES in the SFA is there any ideal concept so far? Wednesday, January 25, 2017 - Time: 11:49-11:55 DEEP DIVE SESSION: Lower limb interventions (part II) Lessons learnt from DES in the SFA is there any ideal concept so far? S.Müller-Hülsbeck, MD, EBIR,

More information

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Thomas M. Shimshak, MD Heart and Vascular Center Florida Hospital Heartland Medical Center

More information

The Burden of CLI and Crosser Catheter Recanalization Strategies

The Burden of CLI and Crosser Catheter Recanalization Strategies , LLC an HMP Communications Holdings Company November 2013 Volume 25/ Supplement D www.invasivecardiology.com The Official Journal of the International Andreas Gruentzig Society The Burden of CLI and Crosser

More information

Lower Extremity Arterial Disease

Lower Extremity Arterial Disease Lower Extremity Arterial Disease Circulating the Facts About Peripheral Disease Brought to you by the Education Committee of the Society for 1 www.svnnet.org Peripheral Artery Disease (PAD) Many people

More information

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention

Disclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention In-Stent Restenosis: The Tail IS Wagging the Dog Disclosures NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 IF YOU WERE

More information

Are DES and DEB worth the cost in BTK interventions?

Are DES and DEB worth the cost in BTK interventions? Are DES and DEB worth the cost in BTK interventions? Thomas Zeller, MD University Heart-Center Freiburg-Bad Krozingen Bad Krozingen, Germany -1- My Disclosures: Advisory Board: Medtronic-Invatec, Gore,

More information

4/14/2016. Faculty Disclosure. Drug-eluting technology in the SFA and Popliteal. Typical SFA Disease Pattern. Why Peripheral Artery Disease Matters

4/14/2016. Faculty Disclosure. Drug-eluting technology in the SFA and Popliteal. Typical SFA Disease Pattern. Why Peripheral Artery Disease Matters Drug-eluting technology in the SFA and Popliteal David Paul Slovut, MD, PhD Associate Professor of Medicine and Surgery Co-director of TAVR program Director of Advanced Intervention Faculty Disclosure

More information

Chronic total occlusions (CTOs)

Chronic total occlusions (CTOs) Case Report Hellenic J Cardiol 2011; 52: 86-90 Use of the Frontrunner Catheter to Cross a Chronic Total Occlusion of the Left Subclavian Artery Tesfaldet T. Michael, Subhash Banerjee, Emmanouil S. Brilakis

More information

Evidence-Based Optimal Treatment for SFA Disease

Evidence-Based Optimal Treatment for SFA Disease Evidence-Based Optimal Treatment for SFA Disease Endo first Don t burn surgical bridge Don t stent if possible Javairiah Fatima, MD Assistant Professor of Surgery Division of Vascular and Endovascular

More information

Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel

Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel Case Reports in Vascular Medicine Volume 2015, Article ID 725168, 4 pages http://dx.doi.org/10.1155/2015/725168 Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel Alexander

More information

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014

PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare

More information

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia

Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Traci A. Kimball, MD Department of Surgery Grand Rounds Septemember 13, 2010 Overview Defining Critical Limb Ischemia Epidemiology

More information

Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS

Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS Asymptomatic mass - 38-40%will develop symptoms at a rate of 14%/yr Intermittent claudic ation (chronic ischemia) - 25%-40%

More information

Berman distal revascularization-interval

Berman distal revascularization-interval 13 487 491 2004 distal revascularization-interval ligation DRIL 75 2003 11 10 20 0 mmhg 35 distal revascularization-interval ligation DRIL 90mmHg 0.56 DRIL 13 487 491 2004 70 1 dialysis access-associated

More information

Remote Endarterectomy Update

Remote Endarterectomy Update Remote Endarterectomy Update An endovascular alternative to bypass? BY JOHN D. MARTIN, MD Treating the superficial femoral artery (SFA) is still one of the most highly debated topics among vascular specialists.

More information